Unequal distribution of cognitive deficits in vascular dementia--is this a valid criterion in the ICD-10?

P F Boston1, M S Dennis, C Jagger

  • 1Michael Carlisle Centre, Nether Edge Hospital, Sheffield, S11 9BJ, UK.

Insights

The ICD-10 criterion for vascular dementia, requiring unequal cognitive deficits, may not be clinically useful. This study found no significant differences in cognitive deficit patterns between vascular dementia and Alzheimer's disease patients.

Area of Science:

  • Neurology
  • Gerontology
  • Psychiatry

Background:

  • The International Classification of Diseases, 10th Revision (ICD-10) criterion for vascular dementia (VaD) posits unequal distribution of cognitive deficits.
  • The clinical utility of this criterion in differentiating VaD from other dementias, such as Alzheimer's disease (AD), requires empirical investigation.

Purpose of the Study:

  • To evaluate the appropriateness of the ICD-10 criterion for VaD, specifically the requirement for unequal cognitive deficits across different domains.
  • To compare cognitive deficit patterns in VaD and AD patients.

Main Methods:

  • A cross-sectional comparative study was conducted using data from a specialist memory clinic in Sheffield and a general practice community sample in Melton Mowbray.
  • The Cambridge Mental Disorders of the Elderly Examination (CAMDEX), including the CAMCOG cognitive assessment, was administered to 131 Sheffield subjects and 396 Melton Mowbray subjects.
  • Depression levels were also assessed as a potential confounding factor.

Main Results:

  • After adjusting for age, sex, and depression scores, no significant differences in the total variability of cognitive deficits were found between VaD and AD subjects at either center.
  • There were minimal differences in individual subscale item performance between the diagnostic groups.
  • In Sheffield, VaD subjects exhibited significantly higher depression scores than AD subjects.

Conclusions:

  • The findings cast doubt on the usefulness of the concept of unequal cognitive deficits as a diagnostic criterion for vascular dementia in routine clinical practice.
  • The diagnostic criteria for vascular dementia may need re-evaluation to improve clinical applicability.
Abstract

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...